Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000937027 | SCV001082801 | benign | Pyruvate dehydrogenase E1-alpha deficiency | 2024-01-11 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002409231 | SCV002711090 | likely benign | Inborn genetic diseases | 2019-10-23 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Natera, |
RCV001826976 | SCV002076940 | likely benign | Pyruvate dehydrogenase complex deficiency | 2020-08-28 | no assertion criteria provided | clinical testing |